Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Palestinian Ministry of Health: Two were martyred in Israeli shelling that targeted a besieged house in the town of Qabatiya in Jenin
At least 68 dead in migrant shipwreck off Yemen: IOM
Trump: We want to feed the people in Gaza, we do not want them to starve.
US President Donald Trump: We will impose sanctions on Russia if it does not end the war on Ukraine.
Israeli media: Polls show that 52% oppose Prime Minister Benjamin Netanyahu while only 29% support him.
Israeli media: 32% of Americans still support "Israel's" war on Hamas, while 60% oppose it.
Israeli media: Core US support for "Israel" hits its lowest, while support for Palestine reaches its highest levels.
Al Mayadeen's correspondent reports martyrs, injuries in Israeli bombardment of home in Heker al-Jame area in Deir al-Balah, central Gaza.
Al-Quds Governorate: Today, the spatial division of Al-Aqsa Mosque began in a public and dangerous manner, and we warn of a religious war in the region
The Ministry of Health in Gaza: This brings the total number of victims of famine and malnutrition to 175, including 93 children

Hopes for cancer cure as personal mRNA vaccine for melanoma trialled

  • By Al Mayadeen English
  • Source: News Websites
  • 26 Apr 2024 16:53
  • 1 Shares
3 Min Read

Experts are currently studying new jabs that are custom-built for each patient and instruct their bodies to hunt out cancer cells to prevent the return of the disease.

  • x
  • Hopes for cancer cure as personal mRNA vaccine for melanoma trialled
    A nurse administers the third dose of an experimental breast cancer vaccine to patient Kathleen Jade at the University of Washington Medical Center in Seattle on May 30, 2023 (AP)

Physicians have begun testing the world's first personalized mRNA cancer vaccine for melanoma on a number of patients, with experts hailing its "game-changing" ability to irreversibly cure cancer. 

Melanoma affects around 132,000 individuals worldwide each year and is the leading cause of death from skin cancer. Currently, surgery is the primary treatment, however radiation, medications, and chemotherapy are occasionally employed.

Experts are currently studying new jabs that are custom-built for each patient and instruct their bodies to hunt out cancer cells to prevent the return of the disease.

A phase 2 experiment indicated that the immunizations significantly lowered the probability of cancer recurrence in melanoma patients. A final phase 3 experiment has been initiated, conducted by University College London Hospitals NHS Foundation Trust (UCLH).

MRNA therapy was administered to the first UK patients in February to evaluate the therapy’s safety and effectiveness in treating melanoma, lung cancer, and other solid tumors.

Dr. Heather Shaw, the trial's national coordinating investigator, indicated that the shots have the potential to cure melanoma and are being studied for other malignancies such as lung, bladder, and kidney.

Read more: Dr. Philip Salem: Lebanese architect of the cancer cure, ICTriplex

Shaw called the technology a “really finely honed tool," adding that the patients are "really excited about them."

Related News

Biden diagnosed with 'aggressive' prostate cancer

Senate report reveals Trump slashed cancer research by 31%

The vaccination is an individualized neoantigen treatment. It is meant to activate the immune system so that it can fight back against a patient's particular kind.

The mRNA-4157 (V940) vaccine, targets cancer neoantigens that are expressed by tumors in a specific patient. These are tumor-specific signals that the immune system may identify.

The jab contains code for up to 34 neoantigens and stimulates an anti-tumor immune response based on the specific mutations found in a patient's malignancy.

To personalize it, a tumor sample is extracted during the patient's operation, which is then sequenced using DNA and artificial intelligence. As a consequence, the patient receives a personalized anti-cancer vaccine tailored to his or her tumor.

“It is absolutely custom-built for the patient," Shaw cited. “They may have some shared new antigens, but they’re likely to have their own very individual new antigens that are important to their tumour and so, therefore, it is truly personalized.”

Shaw stated that the ultimate goal is to permanently cure people of cancer

According to Phase 2 data, persons with significant high-risk melanomas who received the jab alongside the immunotherapy Keytruda were nearly half (49%) as likely to die or have their disease return after three years as those who had only Keytruda.

Patients received 1mg of the mRNA vaccine every three weeks for a maximum of nine doses, followed by 200mg of Keytruda every three weeks (maximum of 18 doses) for approximately a year.

The phase 3 worldwide study will now encompass a broader variety of patients and seeks to enroll around 1,100 participants. The UK arm plans to enroll at least 60 to 70 patients across eight centers, including London, Manchester, Edinburgh, and Leeds.

Steve Young, 52, of Stevenage, Hertfordshire, is one of the first patients to participate in the UCLH experiment. "I'm really, really excited," he remarked. "This is my best chance at stopping the cancer in its tracks."

  • Cancer
  • Cancer patients
  • cancer treatment
  • cancer research
  • mRNA
  • melanoma

Most Read

A rescued crew member from the ETERNITY C vessel in a video released by the Yemeni Armed Forces on July 28, 2025 (Yemeni Military Media)

Yemen Navy reveals fate of targeted Eternity C ship crew

  • Politics
  • 28 Jul 2025
An Israeli tank explodes following an ambush by al-Qassam Brigades in Gaza, Occupied Palestine, undated (Al-Qassam Military Media)

Al-Qassam strikes Israeli vehicles in Gaza, inflicts casualties

  • Politics
  • 30 Jul 2025
UAE lodges complaint against Israeli ambassador over 'misbehavior'

UAE lodges complaint against Israeli ambassador over 'misbehavior'

  • Politics
  • 1 Aug 2025
Protesters chant anti-Israeli slogans as they carry a banner that reads:" Freedom for Palestine, Alliance stop the war," during a demonstration in support of Palestinians in Gaza, outside the Israeli embassy, in Athens, Monday, June 9, 2025 (AP)

Athens mayor slams Israeli ambassador over Gaza war, graffiti claim

  • Politics
  • 3 Aug 2025

Coverage

All
The Ummah's Martyrs

Read Next

All
A member of the al-Qassam Brigades, the armed wing of Hamas, takes part in a parade as he celebrates a ceasefire agreement between Hamas and the Israeli regime in Deir al-Balah, Gaza Strip, Sunday, January 19, 2025 (AP)
Politics

Al-Qassam: We’ll allow aid to Israeli captives if Gaza siege ends

Freed Lebanese freedom fighter Georges Abdallah during an interview on Al Mayadeen, which aired on Sunday, August 3, 2025 (Al Mayadeen screengrab)
Politics

Exclusive: Resistance key to building state, Georges Abdallah says

United Nations Secretary General Antonio Guterres gives a statement about the situation in Gaza at UN headquarters, Friday, June 27, 2025 (AP)
Politics

UN warns Gaza faces water crisis, looming famine under Israeli siege

Israeli soldiers drive their armored personnel carrier along the Gaza Strip, in southern occupied Palestine, Wednesday, July 30, 2025 (AP)
Politics

Ex-Israeli general says Gaza starvation campaign isolated 'Israel'

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS